https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2004-04-20 14:31:422016-11-28 14:32:04SuperGen (Nasdaq: SUPG) Will Webcast Its Scientific Review and Corporate Update for Investors
https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2004-04-19 14:32:132016-11-28 14:33:18Astex achieves second milestone in Alzheimer’s drug discovery collaboration with AstraZeneca
https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2004-03-31 14:33:282016-11-28 14:33:49SuperGen Reports Results from Dacogen™ Phase III Study in Myelodysplastic Syndromes (MDS)
https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2004-03-26 14:34:002016-11-28 14:34:22SuperGen’s New Drug Application for Orathecin™ (rubitecan) Capsules Accepted by FDA for Filing
https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2004-03-22 14:34:312016-11-28 14:34:48Astex, The Wellcome Trust, The Institute of Cancer Research and Cancer Research Technology announce major cancer drug discovery collaboration
https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2004-03-10 13:35:312016-11-28 14:43:07SuperGen Releases Interim Data Clarification From Dacogen™ Phase III Clinical Study in Myelodysplastic Syndrome Following Analyst/Investigator Conference Call
https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2004-03-05 14:36:092016-11-28 14:36:34SuperGen Announces Private Placement of $34 Million of Stock and Warrants
https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2004-03-02 14:36:432016-11-28 14:37:07Published Study Results Show Low-Dose Outpatient Dosing Schedule of Dacogen™ Useful in Patients With Hematological Malignancies
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok